AnaptysBio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Net Income	-163.62	-128.72	-57.8	-19.93	-97.34	-61.66	-30.07	-4.26	-5.41	0.23
Depreciation & Amortization	2.38	2.34	2.09	1.62	1.41	0.32	0.18	0.23	0.27	0.31
Share-Based Compensation	33.21	27.36	15.35	11.5	12.41	9.96	4.38	1.16	0.6	0.16
Other Operating Activities	7.24	25.44	-5.56	-7.34	14	2.87	6.07	-6.16	-5.17	10.6
Operating Cash Flow	-120.8	-73.59	-45.92	-14.16	-69.52	-48.51	-19.44	-9.03	-9.69	14.6
Capital Expenditures	-0.81	-0.36	-1.35	-0.57	-0.81	-1.06	-0.29	-0.05	-0.24	-0.14
Change in Investments	145.56	-394.49	40.19	95.04	132.24	-141.39	-242.77	0	0	0
Investing Cash Flow	144.75	-394.85	38.84	94.48	131.43	-142.45	-243.06	-0.05	-0.24	-0.14
Share Issuance / Repurchase	-47.53	11.83	2.55	0.5	3.01	230.35	293.52	0.03	0.16	0
Debt Issued / Paid	-11.73	-2.47	0	-1.38	-7.5	-6.88	0	9.75	0	4.92
Other Financing Activities	-0.04	34.66	249.75	-	-	-0.11	-1.06	-1.15	39.24	-
Financing Cash Flow	-59.3	44.02	252.3	-0.88	-4.49	223.36	292.45	8.63	39.4	4.92
Net Cash Flow	-35.34	-424.42	245.21	79.44	57.42	32.41	29.96	-0.45	29.47	19.38
Free Cash Flow	-121.61	-73.95	-47.27	-14.73	-70.32	-49.57	-19.73	-9.08	-9.93	14.46
Free Cash Flow Margin	-708.79%	-718.88%	-74.83%	-19.63%	-879.03%	-991.38%	-197.28%	-54.42%	-56.52%	91.32%
Free Cash Flow Per Share	-4.52	-2.63	-1.72	-0.54	-2.60	-2.01	-1.00	-3.44	-3.89	5.83

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).